← Leaderboards
Ian F. Pollack
University Of Pittsburgh At Pittsburgh
$10,728,894
Attributed
$11,038,541
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–20$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$23,691,825 · 11
By mechanism
P01$15,388,857 · 5
R01$7,192,370 · 3
R21$619,295 · 1
U01$483,163 · 1
M01$8,140 · 1
Top collaborators
- Hideho Okada2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- David H Waldeck$940,807
- Guy Salama$8,126,728
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaClinical ResearchResourcesBaseTumorChemotherapyIrradiationFoundationsGenotypeChildhood Brain NeoplasmChildPathway InteractionsResponseMalignant GliomaBrain NeoplasmsPeptidesVaccinationAnaplastic AstrocytomaResistanceBiologicalChildhood GliomaExcisionDesignChildren&Apos
Grant awards (52)
Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas$352,785
R01 · FY2020 · CA · contact PI
Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas$342,201
R01 · FY2019 · CA · contact PI
Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas$352,786
R01 · FY2018 · CA · contact PI
Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas$356,618
R01 · FY2017 · CA · contact PI
Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas$357,496
R01 · FY2016 · CA · contact PI
Molecular Markers as Predictors of Outcome in Gliomas$333,281
R01 · FY2015 · NS · contact PI
Peptide vaccine-based immunotherapy for children with recurrent ependymomas.$319,550
R01 · FY2015 · CA · contact PI
Molecular Markers as Predictors of Outcome in Gliomas$329,895
R01 · FY2014 · NS · contact PI
Peptide vaccine-based immunotherapy for children with recurrent ependymomas.$309,460
R01 · FY2014 · CA · contact PI
Molecular Markers as Predictors of Outcome in Gliomas$321,512
R01 · FY2013 · NS · contact PI
Peptide vaccine-based immunotherapy for children with recurrent ependymomas.$316,438
R01 · FY2013 · CA · contact PI
Novel Strategies for Brain Tumor Therapy$1,237,376
P01 · FY2012 · NS · contact PI
Molecular Markers as Predictors of Outcome in Gliomas$333,121
R01 · FY2012 · NS · contact PI
Signal transduction modulation as a therapy for malignant gliomas$319,964
P01 · FY2012 · NS · contact PI
Administration$166,085
P01 · FY2012 · NS · contact PI
Novel Strategies for Brain Tumor Therapy$1,237,378
P01 · FY2011 · NS · contact PI
Molecular Markers as Predictors of Outcome in Gliomas$344,337
R01 · FY2011 · NS · contact PI
Signal transduction modulation as a therapy for malignant gliomas$319,483
P01 · FY2011 · NS · contact PI
Peptide-Based Vaccine Therapy for Childhood Malignant Gliomas$304,932
R21 · FY2011 · CA · contact PI
Administration$166,086
P01 · FY2011 · NS · contact PI
Novel Strategies for Brain Tumor Therapy$1,237,376
P01 · FY2010 · NS · contact PI
Signal transduction modulation as a therapy for malignant gliomas$319,013
P01 · FY2010 · NS · contact PI
Peptide-Based Vaccine Therapy for Childhood Malignant Gliomas$314,363
R21 · FY2010 · CA · contact PI
Administration$166,086
P01 · FY2010 · NS · contact PI
Novel Strategies for Brain Tumor Therapy$949,875
P01 · FY2009 · NS · contact PI
Molecular Markers as Predictors of Outcome in Gliomas$291,993
R01 · FY2009 · NS · contact PI
Signal transduction modulation as a therapy for malignant gliomas$244,544
P01 · FY2009 · NS · contact PI
Administration$127,496
P01 · FY2009 · NS · contact PI
Novel Strategies for Brain Tumor Therapy$1,240,698
P01 · FY2008 · NS · contact PI
Molecular Markers as Predictors of Outcome in Gliomas$324,435
R01 · FY2008 · NS · contact PI
Signal transduction modulation as a therapy for malignant gliomas$320,932
P01 · FY2008 · NS · contact PI
Administration$165,722
P01 · FY2008 · NS · contact PI
Molecular Markers as Predictors of Outcome in Gliomas$324,435
R01 · FY2007 · NS · contact PI
Novel Strategies for Brain Tumor Therapy$1,268,101
P01 · FY2006 · NS · contact PI
Molecular Markers as Predictors of Outcome in Gliomas$334,125
R01 · FY2006 · NS · contact PI
Novel Strategies for Brain Tumor Therapy$1,415,436
P01 · FY2005 · NS
Molecular Markers as Predictors of Outcome in Gliomas$328,877
R01 · FY2005 · NS
Novel Strategies for Brain Tumor Therapy$1,379,728
P01 · FY2004 · NS
Molecular Markers as Predictors of Outcome in Gliomas$330,344
R01 · FY2004 · NS
Gene Therapy of Malignant Gliomas: A Phase I Study$8,140
M01 · FY2004 · RR
Novel Strategies for Brain Tumor Therapy$1,349,527
P01 · FY2003 · NS
Molecular Markers as Predictors of Outcome in Gliomas$332,418
R01 · FY2003 · NS
NOVEL TREATMENT APPROACHES FOR PEDIATRIC BRAIN TUMORS$113,473
U01 · FY2003 · CA
Novel Strategies for Brain Tumor Therapy$77,000
P01 · FY2003 · NS
Novel Strategies for Brain Tumor Therapy$1,260,789
P01 · FY2002 · NS
Molecular Markers as Predictors of Outcome in Gliomas$346,888
R01 · FY2002 · NS
CORE -- BIOSTATISTICS /CLINICAL SUPPORT$210,131
P01 · FY2002 · NS
SIGNAL TRANSDUCTION AS THERAPY FOR MALIGNANT GLIOMAS$210,031
P01 · FY2002 · NS
NOVEL TREATMENT APPROACHES FOR PEDIATRIC BRAIN TUMORS$127,791
U01 · FY2002 · CA
NOVEL TREATMENT APPROACHES FOR PEDIATRIC BRAIN TUMORS$125,021
U01 · FY2001 · CA
MOLECULAR MARKERS AS PREDICTORS OF OUTCOME IN GLIOMAS$209,375
R01 · FY2000 · NS
NOVEL TREATMENT APPROACHES FOR PEDIATRIC BRAIN TUMORS$116,878
U01 · FY2000 · CA